Abstract

Aim: Intraplaque (IP) microvessels have a major causative effect on atherosclerotic plaque development. An increase in microvessel density in ruptured versus nonruptured human plaques suggests that VEGF and other angiogenic factors promote atherosclerosis and potentially destabilize plaques. Because apolipoprotein deficient mice with a heterozygous mutation (C1039G+/-) in the fibrillin-1 gene (ApoE-/-Fbn1C1039G+/-) manifest substantial IP neovascularization, they represent a unique tool to investigate angiogenesis and its role in atherosclerosis. Here, we examined whether administration of axitinib (inhibitor of VEGF receptor-1,-2 and -3) inhibits IP neovascularization and stabilizes atherosclerotic plaques.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call